Loading…
SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.
Also known as: SHIRE HUMAN GENETIC THERAPIES
Firm Income Reported for This Client
$80K
Not substituted for client expenses
Summary
Shire Human Genetic Therapies AB is an organization. Its political footprint includes $80K in lobbying-firm income reported for this client. Lobbying activity focuses on Medical/Disease Research/Clinical Labs. Political activity spans from 2007 to 2009.
Legal entity: GLEIF